![](https://i1.wp.com/hrnxt.com/wp-content/uploads/2020/07/Biocon-Biologics.jpg?resize=200%2C112&ssl=1)
Biocon Ltd, an innovation-led global biopharmaceuticals company, announced that the Board of its subsidiary Biocon Biologics India Limited (Biocon Biologics) has approved a primary equity investment by Tata Capital Growth Fund. As per the terms of the proposed agreement, Tata Capital will invest Rs 225 Crore for a 0.85% minority stake in the biosimilar business,…